Bone health and glucocorticoid-containing lymphoma therapy - a review of risk factors and preventative measures.

Eyre, Toby A; Jensen, Paw; Booth, Stephen; El-Galaly, Tarec Christoffer

Eyre, Toby A; Jensen, Paw; Booth, Stephen; El-Galaly, Tarec Christoffer.

Affiliation

Eyre TA; Department of Haematology, Haematology and Cancer Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Jensen P; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.
Booth S; Department of Haematology, Royal Berkshire Hospital NHS Foundation Trust, Reading, UK.
El-Galaly TC; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.

Br J Haematol ; 198(3): 431-442, 2022 08.

Article in En | MEDLINE | ID: mdl-35235226

Subject(s)

Lymphoma; Osteoporosis; Bone Density; Glucocorticoids/adverse effects; Humans; Lymphoma/drug therapy; Osteoporosis/chemically induced; Osteoporosis/prevention & control; Prospective Studies; Retrospective Studies; Risk Factors

Key words

bone mineral density; fracture; glucocorticoids; late toxicity; lymphoma; osteoporosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Lymphoma Type of study: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2022 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google